BANK OF MONTREAL /CAN/ - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$285,000
-8.7%
11,909
-40.8%
0.00%
Q4 2020$312,000
+88.0%
20,105
+72.0%
0.00%
Q3 2020$166,000
-27.8%
11,690
-5.0%
0.00%
Q2 2020$230,000
+2455.6%
12,302
+485.8%
0.00%
Q1 2020$9,000
-81.6%
2,100
-79.5%
0.00%
Q4 2019$49,000
+2.1%
10,239
+29.5%
0.00%
Q3 2019$48,000
-4.0%
7,906
+2.8%
0.00%
Q2 2019$50,000
+127.3%
7,687
+145.4%
0.00%
Q1 2019$22,000
+22.2%
3,133
-18.7%
0.00%
Q4 2018$18,000
-30.8%
3,853
+10.4%
0.00%
Q3 2018$26,000
+18.2%
3,490
-0.3%
0.00%
Q2 2018$22,000
+29.4%
3,501
+11.7%
0.00%
Q1 2018$17,000
+112.5%
3,133
+302.2%
0.00%
Q3 2017$8,000
-11.1%
7790.0%0.00%
Q2 2017$9,000
-10.0%
7790.0%0.00%
Q1 2017$10,000
+11.1%
7790.0%0.00%
Q4 2016$9,0000.0%7790.0%0.00%
Q3 2016$9,000
-75.0%
779
-80.5%
0.00%
Q2 2015$36,000
-30.8%
4,0000.0%0.00%
Q1 2015$52,000
+92.6%
4,000
+100.0%
0.00%
Q4 2014$27,000
+50.0%
2,0000.0%0.00%
Q3 2014$18,000
-53.8%
2,000
-30.8%
0.00%
Q2 2014$39,000
+95.0%
2,890
+44.5%
0.00%
Q1 2014$20,000
-25.9%
2,0000.0%0.00%
Q4 2013$27,000
+12.5%
2,0000.0%0.00%
Q3 2013$24,000
+14.3%
2,0000.0%0.00%
Q2 2013$21,0002,0000.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders